Chapter 5. Multipotent Adult Progenitor Cells: An Update
- Gregory Bock Organizer,
- Jamie Goode
Published Online: 7 OCT 2008
DOI: 10.1002/0470091452.ch5
Copyright © Novartis Foundation 2005
Book Title

Stem Cells: Nuclear Reprogramming and Therapeutic Applications: Novartis Foundation Symposium 265
Additional Information
How to Cite
Verfaillie, C. M. (2008) Multipotent Adult Progenitor Cells: An Update, in Stem Cells: Nuclear Reprogramming and Therapeutic Applications: Novartis Foundation Symposium 265 (eds G. Bock and J. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470091452.ch5
Publication History
- Published Online: 7 OCT 2008
- Published Print: 18 MAR 2005
ISBN Information
Print ISBN: 9780470091432
Online ISBN: 9780470091456
- Summary
- Chapter
Keywords:
- multipotent adult progenitor cell (MAPC);
- embryonal stem (ES) cell;
- comparative genomic hybridization (CGH);
- gene profile of MAPCs;
- cell exist in vivo;
- in vivo transplantation;
- cell a culture artefact;
- non-senescent nature of MAPCs;
- cell density;
- in vitro differentiation
Summary
The quintessential stem cell is the embryonal stem (ES) cell which has unlimited self-renewal and multipotent differentiation potential. Stem cells have also been identified in most tissues. Compared with ES cells, tissue-specific stem cells have less self-renewal ability and, although they differentiate into multiple lineages, they are not multipotent. A large number of recent published studies have suggested that tissue-specific stem cells may have the ability to generate cells of tissues from unrelated organs. We have identified a population of primitive cells in normal human, rodent, and possibly other mammalian postnatal tissues that have, at the single cell level, multipotent differentiation and extensive proliferation potential, which we named multipotent adult progenitor cell (MAPC). We will discuss studies aimed at determining whether MAPCs also exist in bone marrow of other species, whether MAPCs exist in vivo or are a culture phenomenon, to further characterize MAPCs using gene expression profiling, and effects of in vivo transplantation of MAPCs.
